Why the 4DMedical (ASX:4DX) share price is slipping today

The 4DMedical Ltd (ASX: 4DX) share price is slipping today after the company released its activity report for the second quarter of FY2021.

| More on:
asx share price fall represented by lady in striped tshirt making sad face against orange background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The 4DMedical Ltd (ASX: 4DX) share price is slipping to the downside this morning after the company released its activity report for the second quarter of FY2021.

At the time of writing, the 4DMedical share price is trading hands at $2.20, down 2.22%.

Let's take a look at a few of the details highlighted in the company's quarterly report.

Quarterly highlights

Clinical and commercial progress

The medical imaging company highlighted its continued steps forward for commercialisation of its proprietary XV Technology. On 18 December 2020, 4DMedical delivered its first commercial use case of its XV Lung Ventilation Analysis Software (XV LVAS) with its scan of a patient in Victoria. Following this, the company will be rolling out the XV LVAS software to hospitals and imaging centres nationwide.

Efforts in the US rollout have been delayed due to the impacts of COVID-19. However, 4DMedical noted in the update that during this time the company has built a significant pipeline of pilot programs with hospitals.

Currently, 4DMedical is partnered with the University of Miami Health System through a research program in the US. The quarterly updated that a number of studies are expected to commence in the coming months.  

More recently, 4DMedical announced its first US pilot program for its XV LVAS software. The clinical study will be carried out in partnership with St Joseph Hospital in Orange County, California. XV LVAS will reportedly be used to screen for a variety of lung issues, including COVID-19.

By the numbers

4DMedical reported $101,000 in cash receipts from customers during the quarter. This revenue stemmed from the preclinical software use. In addition to this, the company received $80,000 in government subsidies.

The company had a net cash outflow of $4.64 million during the quarter, leaving the company's cash balance at $43.04 million at 31 December 2020.

Other highlights

4DMedical were approved for the Australian R&D tax incentive scheme for overseas findings during the quarter. This will enable the company to receive credits for up to 43.5% of eligible overseas R&D expenditure.

Late in December, (ASX: 4DX) was also added to the S&P/ASX All Technology Index (ASX: XTX)

4DMedical share price snapshot

The 4DMedical share price is now down roughly 10% year to date (YTD). Comparatively, the S&P/ASX 200 Index (ASX: XJO) is down 1.3% YTD.

Including today's movement in the 4DMedical share price, the company's market capitalisation is now $582 million.

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ ASX Shares

a woman wearing a close-sitting hat featuring wires and thick computer screen glasses clutches her computer monitor and looks shocked and disturbed as she reads old-fashioned computer text from the screen.
Technology Shares

Here's why ASX 200 tech shares (ASX:XTX) outperformed today

ASX tech shares have taken a turn for the better today.

Read more »

Worker in hard hat looks puzzled with one hand on chin
Resources Shares

Why did the Rio Tinto share price (ASX:RIO) have such a lousy 2021?

We look at what happened to this ASX 200 mining giant's shares last year

Read more »

a miner wearing a hard hat smiles as he stands in front of heavy earth moving equipment on a barren mine site.
Share Gainers

Here's why the Rumble Resources (ASX:RTR) share price is climbing 5%

The mineral explorer's share price is on the rise amid promising drill results.

Read more »

share price high, all time record, record share price, highest, price rise, increase, up,
⏸️ ASX Shares

Here are the top 10 ASX 200 shares on Wednesday

Here are your top 10 biggest gainers in the ASX 200 on Wednesday.

Read more »

comical investor reading documents and surrounded by calculators
⏸️ ASX Shares

The ASX reporting wrap-up: WiseTech, Bravura, Seven Group

Just what the investor ordered. Here’s a recap of the companies that reported on Wednesday...

Read more »

Doctor performing an ultrasound on pregnant woman
⏸️ ASX Shares

The ASX reporting wrap-up: Ansell, Kogan, Nanosonics

Just what the investor ordered. Here’s a recap of the companies that reported on Tuesday...

Read more »

blue arrows representing a rising share price ASX 200
⏸️ ASX Shares

Here are the top 10 ASX 200 shares on Tuesday

Here are your top 10 biggest gainers in the ASX 200 on Tuesday.

Read more »

unhappy investor considering computer screen
Share Market News

The ASX reporting wrap-up: Charter Hall, Ampol, NIB Holdings

Just what the investor ordered. Here’s a recap of the companies that reported on Monday...

Read more »